Performance of MAST, FAST, and MEFIB in predicting metabolic dysfunction-associated steatohepatitis.

Shi QiXiaodie WeiJinhan ZhaoXinhuan WeiHaiqing GuoJingxian HuQiqige WuYunCalvin Q PanNengwei ZhangJing Zhang

Published in: Journal of gastroenterology and hepatology (2024)

MAST and FAST performed better than MEFIB in diagnosing "at-risk" MASH and MASH using lower cutoff values. Our findings provided evidence for selecting the most accurate noninvasive model to identify patients with MASH or at-risk MASH.

Keyphrases

oxidative stress
high resolution
mass spectrometry
liver fibrosis